Back to search

Article

Association of SGLT-2 Inhibitors with Thyroid Dysfunction: A Drug-Target Mendelian Randomization Study

2023-09-13

Abstract excerpt

Context: Diabetes and thyroid dysfunction are prevalent endocrine disorders. Diabetes substantially increases the incidence of thyroid dysfunction, and the concurrent presence of diabetes and thyroid dysfunction further heightens the risk of adverse events associated with diabetes. However, no studies have been conducted to investigate the impact of novel antidiabetic medications, particularly sodium-glucose co-tr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3523ca83-695a-54fd-b2c9-555cfdd88e4b
DOI
10.21203/rs.3.rs-3332941/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association of SGLT-2 Inhibitors with Thyroid Dysfunction: A Drug-Target Mendelian Randomization StudyDOI 10.21203/rs.3.rs-3332941/v1
Long-Term Efficacy and Safety of GLP-1R Agonist and SGLT2 Inhibitor Therapy in the General Population: A 2x2 Factorial Mendelian Randomization StudySemantic proximity
CETP and SGLT2 inhibitor combination therapy improves glycemic controlSemantic proximity
Sodium-glucose cotransporter 1/2 inhibition and risk of neurodegenerative disorders: A Mendelian randomization study.Semantic proximity
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study.Semantic proximity
The effect of SGLT2 inhibition on immune cells and transplant rejection/failure: A drug-targeted mendelian randomization study.Semantic proximity
Pharmacogenetics and personalized treatment of type 2 diabetesSemantic proximity
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes: An Umbrella ReviewSemantic proximity
Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 DiabetesSemantic proximity
Pharmacological targets of SGLT2 inhibitors on IgA nephropathy and membranous nephropathy: a mendelian randomization studySemantic proximity
Pharmacogenetic studies update in type 2 diabetes mellitusSemantic proximity
Assessment of the association between genetic factors regulating thyroid function and microvascular complications in diabetes: A two-sample Mendelian randomization study in the European populationSemantic proximity
Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview.Semantic proximity
Select a neighboring publication to make it the new centre.